Substance Use Tools & Resources
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Medicare Learning Network Booklet: Telehealth Services
Explains topics related to billing Medicare and Medicaid for telehealth services, such as billing codes, policies, and application during COVID-19
Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit
Mental Health & Suicide Prevention National Response to COVID-19
The Action Alliance’s Mental Health & Suicide Prevention National Response to COVID-19 (National Response) is a diverse, nonpartisan public-private partnership committed to driving meaningful, lasting change in mental health and suicide prevention through collaboration, leadership, and action. The National Response is working to create sustainable and comprehensive solutions to the mental health impacts of this pandemic, while also preparing to address future needs by mitigating risks and building resiliency.
MHA's Mental Health Test
National Consortium of Telehealth Resource Centers
Provides assistance, education, and information to organizations and individuals who are actively providing or interested in providing healthcare at a distance through events, resources, webinars, techncial assistance, and an interactive map used to find the affiliated regional telehealth resource center
National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Provides information on evidence-based treatment of OUD. This guideline is the only document of its kind to include all Food and Drug Administration (FDA)-approved medications in one place.
